Skip to main content

Table 6 Serum level of sHLA-G antigens in inflammatory bowel disease (ulcerative colitis and Crohn’s disease) patients and controls distributed according to HLA-G 14-bp insertion/deletion genotypes

From: Susceptibility role of soluble HLA-G and HLA-G 14-bp insertion/deletion polymorphism in inflammatory bowel disease

Groupa

sHLA-G (mean ± SD); ng/ml

p

Ins/Ins

Ins/Del

Del/Del

Control (N = 19:5:6)

122.2 ± 16.6

135.5 ± 15.2

126.0 ± 14.5

0.314

UC (N = 19:6:5)

183.7 ± 17.9

180.0 ± 46.8

179.8 ± 22.4

0.958

CD (N = 21:7:2)

172.5 ± 34.9

165.0 ± 26.2

169.9 ± 27.0

0.894

  1. UC ulcerative colitis, CD Crohn’s disease, SD standard deviation, Ins insertion, Del deletion, p one-way ANOVA (analysis of variance) probability
  2. a Numbers of Ins/Ins, Ins/Del, and Del/Del are given in parentheses, respectively